Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling
about
miR-155 Regulates IL-10-Producing CD24hiCD27+ B Cells and Impairs Their Function in Patients with Crohn's DiseaseAbnormal B-cell development in Systemic Lupus Erythematosus: what the genetics tell us.Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
P2860
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@ast
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@en
type
label
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@ast
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@en
prefLabel
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@ast
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@en
P2093
P2860
P1476
Targeting CD22 with the monocl ...... -cell receptor (BCR) signaling
@en
P2093
Anthony Shock
Geraldine L Shu
Natalia V Giltiay
P2860
P2888
P356
10.1186/S13075-017-1284-2
P577
2017-05-15T00:00:00Z
P6179
1085379337